Showing results (251-260 of 269) with videos related to
Sort By:
Pageof 27
The Journal of Clinical Investigation|December 17, 2013
Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activityChinavenmeni S Velu, Aditya Chaubey, James D Phelan, et al.Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.Nature Immunology|July 18, 2024
Gα13 restricts nutrient driven proliferation in mucosal germinal centersHang T Nguyen, Moyi Li, Rahul Vadakath, et al.Immunity|December 3, 2020
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human LymphomasDevin Dersh, James D Phelan, Megan E Gumina, et al.Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.Cancer Cell|July 31, 2018
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/LymphomaMasao Nakagawa, Arthur L Shaffer, Michele Ceribelli, et al.Cancer Discovery|May 4, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive LymphomasSebastian Scheich, Jiji Chen, Jiamin Liu, et al.Nature Communications|September 17, 2022
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myelomaYandan Yang, Arnold Bolomsky, Thomas Oellerich, et al.Blood Cancer Discovery|November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK InhibitorsArthur L Shaffer, James D Phelan, James Q Wang, et al.Pageof 27